Stockreport

How Ocugen (OCGN) Phase 2 And Phase 3 Milestones Are Reframing The Investment Story [Yahoo! Finance]

Ocugen, Inc.  (OCGN) 
PDF Ocugen's updated fair value estimate of US$10.36 per share, up from US$9.00, has pushed the price target conversation back into focus for many investors. Analysts linki [Read more]